Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding CNCR?
Track your performance easily
CNCR Price & Analysis
CNCR ETF Chart & Stats
Day’s Range― - ―
52-Week Range$9.22 - $17.96
Previous Close$14.51
VolumeN/A
Average Volume (3M)9.45K
AUM13.81M
NAV14.57
Expense Ratio0.79%
Holdings Count77
Beta1.16
Inception DateOct 13, 2015
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding1,250,000
Standard Deviation0.09
10 Day Avg. Volume12,698
30 Day Avg. Volume9,448
Alpha-0.01
Loncar Cancer Immunotherapy ETF (CNCR) Fund Flow Chart
Loncar Cancer Immunotherapy ETF (CNCR) 1 year Net Flows: $1M
CNCR ETF News
CNCR ETF FAQ
What was CNCR’s price range in the past 12 months?
CNCR lowest ETF price was $9.22 and its highest was $17.96 in the past 12 months.
What is the AUM of CNCR?
As of Jul 19, 2024 The AUM of CNCR is 13.81M.
Is CNCR overvalued?
According to Wall Street analysts CNCR’s price is currently Undervalued.
Does CNCR pay dividends?
CNCR does not currently pay dividends.
How many shares outstanding does CNCR have?
CNCR has 1,250,000 shares outstanding.
Which hedge fund is a major shareholder of CNCR?
Currently, no hedge funds are holding shares in CNCR
CNCR ETF Smart Score
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Geron Corporation
3.79%
Summit Therapeutics PLC
2.92%
Enliven Therapeutics, Inc.
2.78%
Iteos Therapeutics, Inc.
2.16%
Nurix Therapeutics, Inc.
2.14%
Acrivon Therapeutics, Inc.
2.12%
Nuvation Bio Inc
2.06%
Erasca, Inc.
2.06%
Revolution Medicines, Inc.
2.05%
Blueprint Medicines Corp.
1.84%
Total23.92%
ETF Description
Loncar Cancer Immunotherapy ETF
CNCR tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products.